Italfarmaco Research
Italy - Cinisello BalsamPharmaceutical
Focus: Italfarmaco Research is a specialty pharmaceutical company based in Cinisello Balsamo, Italy, focused on pharmaceuticals and fine chemicals with a narrow therapeutic focus on neurology. The company derives 95% of revenue from a single asset: riluzole for amyotrophic lateral sclerosis (ALS).
Profile data last refreshed 14h ago · AI intelligence enriched 1w ago
Open Jobs
0
About Italfarmaco Research
AI assessmentNot HiringNo open roles listed right now. Follow Italfarmaco Research to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Italfarmaco Research's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
1 in 5yr
TIGLUTIK KIT
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$8M Part DDeclining
Post-LOE
Core revenue driver generating $8M in Part D spending; multiple generic ANDAs in post-LOE indicate mature, competitive market.
Help build intelligence for Italfarmaco Research
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.